144 related articles for article (PubMed ID: 9422771)
21. Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).
Eissmann P; Beauchamp L; Wooters J; Tilton JC; Long EO; Watzl C
Blood; 2005 Jun; 105(12):4722-9. PubMed ID: 15713798
[TBL] [Abstract][Full Text] [Related]
22. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
23. The rat orthologue to the inhibitory receptor gp49B is expressed by neutrophils and monocytes, but not by NK cells or mast cells.
Bryceson YT; Torgersen KM; Inngjerdingen M; Berg SF; Hoelsbrekken SE; Fossum S; Dissen E
Eur J Immunol; 2005 Apr; 35(4):1230-9. PubMed ID: 15756648
[TBL] [Abstract][Full Text] [Related]
24. KLRG1 binds cadherins and preferentially associates with SHIP-1.
Tessmer MS; Fugere C; Stevenaert F; Naidenko OV; Chong HJ; Leclercq G; Brossay L
Int Immunol; 2007 Apr; 19(4):391-400. PubMed ID: 17307799
[TBL] [Abstract][Full Text] [Related]
25. Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis.
Famiglietti SJ; Nakamura K; Cambier JC
Immunol Lett; 1999 May; 68(1):35-40. PubMed ID: 10397153
[TBL] [Abstract][Full Text] [Related]
26. Decoding protein-protein interactions through combinatorial chemistry: sequence specificity of SHP-1, SHP-2, and SHIP SH2 domains.
Sweeney MC; Wavreille AS; Park J; Butchar JP; Tridandapani S; Pei D
Biochemistry; 2005 Nov; 44(45):14932-47. PubMed ID: 16274240
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a novel tyrosine phosphorylated 100-kDa protein that binds to SHP-2 and phosphatidylinositol 3'-kinase in myeloid cells.
Carlberg K; Rohrschneider LR
J Biol Chem; 1997 Jun; 272(25):15943-50. PubMed ID: 9188495
[TBL] [Abstract][Full Text] [Related]
28. Genomic structures and chromosomal location of p91, a novel murine regulatory receptor family.
Yamashita Y; Fukuta D; Tsuji A; Nagabukuro A; Matsuda Y; Nishikawa Y; Ohyama Y; Ohmori H; Ono M; Takai T
J Biochem; 1998 Feb; 123(2):358-68. PubMed ID: 9538215
[TBL] [Abstract][Full Text] [Related]
29. Requirement of SH2-containing protein tyrosine phosphatases SHP-1 and SHP-2 for paired immunoglobulin-like receptor B (PIR-B)-mediated inhibitory signal.
Maeda A; Kurosaki M; Ono M; Takai T; Kurosaki T
J Exp Med; 1998 Apr; 187(8):1355-60. PubMed ID: 9547347
[TBL] [Abstract][Full Text] [Related]
30. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells.
Zhang S; Mantel C; Broxmeyer HE
J Leukoc Biol; 1999 Mar; 65(3):372-80. PubMed ID: 10080542
[TBL] [Abstract][Full Text] [Related]
31. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
Sármay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
[TBL] [Abstract][Full Text] [Related]
32. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
[TBL] [Abstract][Full Text] [Related]
33. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2.
Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM
Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006
[TBL] [Abstract][Full Text] [Related]
34. An immunoreceptor tyrosine-based inhibitory motif, with serine at site Y-2, binds SH2-domain-containing phosphatases.
Philosof-Oppenheimer R; Hampe CS; Schlessinger K; Fridkin M; Pecht I
Eur J Biochem; 2000 Feb; 267(3):703-11. PubMed ID: 10651806
[TBL] [Abstract][Full Text] [Related]
35. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA.
Huang ZY; Hunter S; Kim MK; Indik ZK; Schreiber AD
J Leukoc Biol; 2003 Jun; 73(6):823-9. PubMed ID: 12773515
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
[TBL] [Abstract][Full Text] [Related]
37. Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
Koncz G; Pecht I; Gergely J; Sármay G
Eur J Immunol; 1999 Jun; 29(6):1980-9. PubMed ID: 10382761
[TBL] [Abstract][Full Text] [Related]
38. Differential association of phosphatases with hematopoietic co-receptors bearing immunoreceptor tyrosine-based inhibition motifs.
Vély F; Olivero S; Olcese L; Moretta A; Damen JE; Liu L; Krystal G; Cambier JC; Daëron M; Vivier E
Eur J Immunol; 1997 Aug; 27(8):1994-2000. PubMed ID: 9295037
[TBL] [Abstract][Full Text] [Related]
39. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
[TBL] [Abstract][Full Text] [Related]
40. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates.
Hua CT; Gamble JR; Vadas MA; Jackson DE
J Biol Chem; 1998 Oct; 273(43):28332-40. PubMed ID: 9774457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
